CPC
KRYS icon

Cookson Peirce & Co’s Krystal Biotech KRYS Stock Holding History

Cookson Peirce & Co’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
4,898
+204
+4% +$61K 0.06% 145
2026
Q1 		$1.21M Sell
4,694
-1,260
-21% -$335K 0.05% 173
2025
Q4 		$1.47M Buy
5,954
+300
+5% +$63.1K 0.06% 141
2025
Q3 		$998K Buy
+5,654
New +$846K 0.04% 174

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Cookson Peirce & Co's KRYS Position: Q2 2026 in Review

Cookson Peirce & Co increased its Krystal Biotech (KRYS) stake by 4.3% in Q2 2026, buying an estimated $61K and bringing the position to 4,898 shares worth $1.82M. The position accounts for 0.06% of the portfolio, ranked #145.

Cookson Peirce & Co first reported a position in KRYS in Q3 2025 and has held it in 4 quarters since. 104 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Cookson Peirce & Co held 4,898 shares of Krystal Biotech worth $1.82M as of Q2 2026.
  • Cookson Peirce & Co bought 204 Krystal Biotech shares in Q2 2026, an estimated $61K.
  • Krystal Biotech made up 0.06% of Cookson Peirce & Co's portfolio in Q2 2026, its #145 holding.
  • Cookson Peirce & Co first reported a position in Krystal Biotech in Q3 2025 and has held it in 4 quarters since.
  • 104 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.